Todd Pawlicki presented on the initial experiences with SGRT for the Halcyon system. He discussed that treatment started in August 2017 with over 190 plans created for over 170 patients. SGRT allows for pre-treatment setup verification, intra-fraction motion monitoring, and has treated over 10 patients per day on average. While SGRT has improved efficiency and accuracy in the short term, opportunities remain in the long term around system safety, extracting health information, and optimizing workflow and monitoring.
Related topics: